Тёмный
RhAPP Digital
RhAPP Digital
RhAPP Digital
Подписаться
RhAPPcast: Navigating Remission in Rheumatoid Arthritis: Approaches, Advances, Impact, and Insights
31:14
RhAPPcast: Navigating Remission in Rheumatoid Arthritis: Approaches, Advances, Impact, and Insights
14 часов назад
RhAPPcast: CD64+ Binding Description, Relevance, and Potential Clinical Implications
19:29
RhAPPcast: CD64+ Binding Description, Relevance, and Potential Clinical Implications
19 часов назад
FAQ: What is the difference between biosimilars and generics?
2:05
FAQ: What is the difference between biosimilars and generics?
День назад
FAQ: What is the ORAL Surveillance study and how can it be applied to clinical practice?
2:43
FAQ: What is the ORAL Surveillance study and how can it be applied to clinical practice?
День назад
Medication Review Video Module: What is the Safety Profile of Ixekizumab in PsA and axSpa
3:17
Medication Review Video Module: What is the Safety Profile of Ixekizumab in PsA and axSpa
14 дней назад
Medication Review Video Module: What is the safety profile of upadacitinib across indications?
10:00
Medication Review Video Module: What is the safety profile of upadacitinib across indications?
14 дней назад
FAQ: Variability in JAK Inhibition Specificity & Its Clinical Implications
3:11
FAQ: Variability in JAK Inhibition Specificity & Its Clinical Implications
14 дней назад
FAQ: Provide Immunologic Rationale For IL23 Directed Therapy in PsA, PsO, and IBD.
3:33
FAQ: Provide Immunologic Rationale For IL23 Directed Therapy in PsA, PsO, and IBD.
21 день назад
RhAPPcast: Biosimilars and The Patient Perspective
22:04
RhAPPcast: Biosimilars and The Patient Perspective
21 день назад
Medication Review Video Module: How is upadacitinib dosed across rheumatologic indications?
1:42
Medication Review Video Module: How is upadacitinib dosed across rheumatologic indications?
Месяц назад
FAQ: Provide immunologic rationale for JAK directed therapy in rheumatic disease
6:37
FAQ: Provide immunologic rationale for JAK directed therapy in rheumatic disease
Месяц назад
Medication Review Video Module: Describe the mechanism of action of upadacitinib
1:11
Medication Review Video Module: Describe the mechanism of action of upadacitinib
Месяц назад
FAQ: Provide Immunologic Rationale For IL17-Directed Therapy in PsA, AS, and nr-axSpA
1:36
FAQ: Provide Immunologic Rationale For IL17-Directed Therapy in PsA, AS, and nr-axSpA
Месяц назад
FAQ: Describe JAK-STAT signaling in inflammation
1:52
FAQ: Describe JAK-STAT signaling in inflammation
Месяц назад
FAQ: Describe the IL17-Induced Inflammatory Cascade
2:46
FAQ: Describe the IL17-Induced Inflammatory Cascade
Месяц назад
FAQ: What Does It Mean for a Biosimilar to Be Interchangeable and Why Is That Important?
2:48
FAQ: What Does It Mean for a Biosimilar to Be Interchangeable and Why Is That Important?
Месяц назад
Journal Club Video Module
3:51
Journal Club Video Module
Месяц назад
Med. Review Video Module: What is Non-Responder Imputation and How is it Utilized in Clinical Trials
2:03
Med. Review Video Module: What is Non-Responder Imputation and How is it Utilized in Clinical Trials
2 месяца назад
RhAPPcast: Biosimilars Unveiled - Empowering APPs for Better Patient Conversations
27:21
RhAPPcast: Biosimilars Unveiled - Empowering APPs for Better Patient Conversations
2 месяца назад
Medication Review Video Module: Describe The Mechanism of Action of Ixekizumab
1:22
Medication Review Video Module: Describe The Mechanism of Action of Ixekizumab
2 месяца назад
FAQ : What is The Role of IL23/IL17 Axis in Rheumatic Disease
2:37
FAQ : What is The Role of IL23/IL17 Axis in Rheumatic Disease
2 месяца назад
RhAPPcast: The IL23/IL17 Cascade and Implications in the Pathogenesis of PsA, PsO, and IBD
23:52
RhAPPcast: The IL23/IL17 Cascade and Implications in the Pathogenesis of PsA, PsO, and IBD
2 месяца назад
FAQ: Describe the IL23/IL17 Axis
2:51
FAQ: Describe the IL23/IL17 Axis
2 месяца назад
Journal Club Video Module: Differentiation of Therapeutic Antibodies Targeting Interleukin (IL)-23
4:25
Journal Club Video Module: Differentiation of Therapeutic Antibodies Targeting Interleukin (IL)-23
2 месяца назад
Medication Review Video Module : Describe The Mechanism of Action of Guselkumab
2:53
Medication Review Video Module : Describe The Mechanism of Action of Guselkumab
2 месяца назад
FAQ: Define, Compare, and Contrast Humoral and Cell-Mediated Immunity
3:23
FAQ: Define, Compare, and Contrast Humoral and Cell-Mediated Immunity
2 месяца назад
Jessica Farrell, PharmD | Most Notable Sentiment from the 2023 RhAPP National Conference
0:28
Jessica Farrell, PharmD | Most Notable Sentiment from the 2023 RhAPP National Conference
Год назад
Jessica Farrell, PharmD | Most Notable Sentiment from 2023 RhAPP National Conference
0:28
Jessica Farrell, PharmD | Most Notable Sentiment from 2023 RhAPP National Conference
Год назад
Amanda Mixon, PA-C | Suggested Diet to Reduce Inflammation
0:32
Amanda Mixon, PA-C | Suggested Diet to Reduce Inflammation
Год назад
Комментарии